Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

• Status: Completed
• Trial end date: 2008-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to compare the effect of arzoxifene to raloxifene on the bone mineral density (bone strength).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Raloxifene Hydrochloride

Criteria

Inclusion Criteria:

• Must have osteoporosis

• Must be between 50 and 75 years old and be able to walk

• Have at least two of your back bones that can be x-rayed

• Have not had a period in at least two years

• Be willing to have blood tests

Exclusion Criteria:

• Have a bone disease other than osteoporosis

• History of estrogen dependent cancer

• History of stroke or certain heart problems

• Possibly have an allergy to raloxifene or arzoxifene

• Have certain abnormal lab values

• History of seizure disorder

• Have unexplained vaginal bleeding or an abnormal pap smear